FAQs

AKG is intended for clinicians treating neurodevelopmental and related disorders, researchers exploring medical advancements, and healthcare professionals looking for peer-reviewed studies and expert discussions.

AKG offers a categorized research database with peer-reviewed articles, some of which may be behind publisher paywalls. It includes AI-powered tools that analyze and interpret research findings, as well as a secure discussion platform where clinicians can engage in case study discussions. Users can also access human-written and AI-generated summaries, advanced search capabilities, and interactive features such as liking, following, commenting on, and downloading articles.

AKG offers a categorized research database with peer-reviewed articles, some of which may be behind publisher paywalls. It includes AI-powered tools that analyze and interpret research findings, as well as a secure discussion platform where clinicians can engage in case study discussions. Users can also access human-written and AI-generated summaries, advanced search capabilities, and interactive features such as liking, following, commenting on, and downloading articles.

AKG had an open-access phase, allowing users to explore its features for free while we finalized development and gathered feedback. The AKG is now officially open for public use and subscription-based service launched October 2025.

AKG includes research on ADHD, adult ASD, ASD diagnosis, alternative therapies, behavioral therapy, biomarkers, brain findings, cerebral folate deficiency, COVID-19, gastrointestinal dysfunction, genetics, medications, mitochondria, neurotransmitters, other comorbidities, pregnancy, regression, seizures, supplements, and toxicants.

AKG aims to improve treatment effectiveness by making the latest research more accessible and actionable. It supports clinicians by optimizing their time, promoting evidence-based best practices, and aiding in the development of new solutions and technologies. The platform also provides insights into patient and caregiver engagement, ensuring that research translates into meaningful, real-world impact.

Users are encouraged to explore AKG during the open-access phase and provide feedback on functionality and usability. Your input will help refine the platform and ensure it meets the needs of the medical and research community before its full launch later 2025.